Depletion of plasma proteins
This invention relates to methods of analysis, and in particular to methods for the preliminary fractionation of samples in which low abundance molecules of interest, for example proteins, polysaccharides or fatty acids, are present together with more abundant molecules of little or no interest. In particular, the invention relates to methods of depletion of high abundance proteins from biological samples. Products and kits for use in the method are also disclosed, and form part of the invention. In one aspect, the invention provides a method of depleting a high-abundance molecule from a biological sample, comprising the steps of a) subjecting the sample to affinity depletion using an affinity support with high affinity for a high abundance molecule, and/or b) immunodepletion using an affinity support coupled to an antibody directed against whole or previously fractionated plasma or serum.
1. A method of depleting a high abundance molecule from a biological sample, comprising the steps of:
a) subjecting the sample to affinity depletion using an affinity support with high affinity for the high abundance molecule; and
b) immunodepleting the sample using an affinity support coupled to a chicken IgY antibody, wherein the chicken IgY antibody is a second generation or higher antibody raised against whole blood, serum or plasma or against whole blood, serum or plasma that has already been subjected to at least one round of affinity depletion or immunodepletion, and wherein the chicken IgY antibody binds a plurality of different high abundance molecules.
2. The method of claim 1 , in which the IgY chicken antibody is a second antibody raised against whole blood, serum or plasma or against whole blood, serum or plasma that has already been subjected to one round of affinity depletion or immunodepletion.
3. A method of depleting a high abundance molecule from a biological sample, comprising the steps of:
a) subjecting the sample to affinity depletion using an affinity support with high affinity for the high abundance molecule; and
b) immunodepleting the sample using an affinity support coupled to a chicken IgY antibody, wherein the chicken IgY antibody is a second generation or higher antibody raised against whole blood, serum or plasma, or against whole blood, serum or plasma that has already been subjected to at least one round of affinity depletion or immunodepletion, and wherein the chicken IgY antibody binds a plurality of different high abundance molecules.
4. The method of claim 1 , wherein the whole blood, serum or plasma is of human origin.
5. The method of claim 1 , in which step (a) is performed before step (b).
6. The method of claim 1 , in which the high abundance molecule is a protein.
7. The method of claim 6 , in which the protein is albumin or immunoglobulin.
8. The method of claim 1 , in which the biological sample is conditioned medium from a cell or tissue culture, or is a tissue or cell extract.
9. The method of claim 1 , in which the affinity support used in step (a) is a dye affinity chromatography resin.
10. The method of claim 9 , in which the dye is a chlorotriazine compound.
11. The method of claim 10 , in which the affinity support is a Cibacron blue F3GA affinity support.
12. The method of claim 1 , in which the affinity support used in step (a) comprises a magnetic bead.
13. A method of separation or analysis of a low abundance molecule in a biological sample, comprising the step of depleting at least one high abundance molecule from the sample by the method of claim 1 , prior to subjecting the sample to one or more separation or analytical steps for the separation or analysis of the low abundance molecule.
14. A method of identifying the expression of a low abundance molecule in a mammal, comprising the step of depleting at least one high abundance molecule from a biological sample from the mammal by the method of claim 1 , prior to subjecting the sample one or more analytical steps to detect the expression of the low abundance molecule.
15. A method of claim 14 , in which a change in the expression of the low abundance molecule is detected.